scieee AI-readable full text Open interactive document viewer

Compatibility of the entomopathogenic fungus Beauveria bassiana with etoxazole, spirodiclofen and spiromesifen against Tetranychus urticae

López-Manzanares, Beatriz,Martínez-Villar, Elena,Marco Mancebón, Vicente,Pérez-Moreno, I.

Abstract

In the Integrated Pest Management of Tetranychus urticae, it is important to use microbiological control agents and acaricides with differing modes of action in order to reduce the risk of resistance, so often reported for this mite. This study evaluates the effect of etoxazole, spirodiclofen, spiromesifen and their compatibility with Beauveria bassiana on the eggs and larvae of T. urticae. For etoxazole and spirodiclofen, the regression lines from the Probit Analysis were parallel in both cases for the two developmental stages. Both acaricides were more effective on eggs than larvae (2.5 and 4.6 times, respectively). The adjusted regression lines of efficacy produced from the bioassays with spiromesifen on eggs and larvae were neither equal nor parallel. However, the confidence intervals for eggs and larvae did overlap at LC, indicating equal sensitivity in both eggs and larvae at this concentration. The mixture of etoxazole with B. bassiana showed clear antagonistic interaction even though this effect was the result of interference with neither conidial germination nor with the fungus mycelial growth. On the other hand, the combinations of B. bassiana with spirodiclofen and with spiromesifen exhibited additive interaction. The results of this research show that the effectiveness of mixtures of B. bassiana with both spirodiclofen and spiromesifen requires product concentrations to be maintained with no possibility of reduction. Furthermore, the antagonistic effect of the mixture of B. bassiana and etoxazole precludes the combined use of these acaricides in the management of the eggs and larvae of this mite.

Full text

Biological Control 169 (2022) 104892 Available online 21 March 2022 1049-9644/© 2022 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/). Compatibility of the entomopathogenic fungus Beauveria bassiana with etoxazole, spirodiclofen and spiromesifen against Tetranychus urticae Beatriz L´ opez-Manzanares a , Elena Martínez-Villar b , Vicente S. Marco-Manceb´ on b , * , Ignacio P´ erez-Moreno b a Institute of Grapevine and Wine Sciences (ICVV), Spanish National Research Council (CSIC), University of La Rioja, Government of La Rioja, Ctra. LO-20 Salida 13, Finca La Grajera, Logro˜ no, Spain b Crop Protection Unit, Department of Agriculture and Food Science, Science and Technology Centre, University of La Rioja, C/Madre de Dios, 51, 26006 Logro˜ no, Spain HIGHLIGHTS GRAPHICAL ABSTRACT •B. bassiana exhibited an additive interaction with spirodiclofen and spiromesifen. •The mixture B. bassiana-etoxazole showed a clear antagonistic interaction. •The antagonism was not due to a decrease in conidial germination or mycelial growth. ARTICLE INFO Keywords: Mite growth inhibitors Tetronic acid derivatives Tetramic acid derivatives Entomopathogenic fungus Two-spotted spider mite Synergism ABSTRACT In the Integrated Pest Management of Tetranychus urticae, it is important to use microbiological control agents and acaricides with differing modes of action in order to reduce the risk of resistance, so often reported for this mite. This study evaluates the effect of etoxazole, spirodiclofen, spiromesifen and their compatibility with Beauveria bassiana on the eggs and larvae of T. urticae. For etoxazole and spirodiclofen, the regression lines from the Probit Analysis were parallel in both cases for the two developmental stages. Both acaricides were more effective on eggs than larvae (2.5 and 4.6 times, respectively). The adjusted regression lines of efficacy produced from the bioassays with spiromesifen on eggs and larvae were neither equal nor parallel. However, the confidence intervals for eggs and larvae did overlap at LC 99 , indicating equal sensitivity in both eggs and larvae at this concentration. The mixture of etoxazole with B. bassiana showed clear antagonistic interaction even though this effect was the result of interference with neither conidial germination nor with the fungus mycelial growth. On the other hand, the combinations of B. bassiana with spirodiclofen and with spiromesifen exhibited additive interaction. The results of this research show that the effectiveness of mixtures of B. bassiana with both spirodiclofen and spiromesifen requires product concentrations to be maintained with no possibility of reduction. Furthermore, the antagonistic effect of the mixture of B. bassiana and etoxazole precludes the combined use of these acaricides in the management of the eggs and larvae of this mite. * Corresponding author. E-mail addresses: [email protected] (E. Martínez-Villar), [email protected] (V.S. Marco-Manceb´ on), [email protected] (I. P´ erezMoreno). Contents lists available at ScienceDirect Biological Control journal homepage: www.elsevier.com/locate/ybcon https://doi.org/10.1016/j.biocontrol.2022.104892 Received 27 July 2021; Received in revised form 9 March 2022; Accepted 11 March 2022 Biological Control 169 (2022) 104892 2 1. Introduction The two-spotted spider mite, Tetranychus urticae Koch (Acari: Tetranychidae), is a significant pest in numerous food and fibre crops and ornamental plants, and is considered to be a key pest in regions with temperate climates. This mite is also considered the most polyphagous within the Tetranychidae family (Van de Vrie, 1985). Due to its elevated reproduction rate and short life cycle, this mite can reach economic thresholds quickly. The rapid increase in population densities in turn leads to the use of acaricides, which negatively affect the abundance of natural enemies. In addition, the rapid development of resistance to common chemical pesticides continues to make the control of this pest a true challenge. Thus, two key aspects, which must be kept in mind in Integrated Pest management (IPM) strategies against T. urticae are the protection of natural enemies and the use of selective acaricides with diverse modes of action. One basic feature of IPM is the use of biological control agents compatible with chemical pesticides, which is not only effective but also engenders fewer toxicological problems and protects the environment. In this context, we studied the compatibility of mixtures of the entomopathogenic fungus Beauveria bassiana (Balsamo) Vuillemin with the acaricides etoxazole, spirodiclofen and spiromesifen. B. bassiana is a cosmopolitan, soil fungus, which has been shown to be a useful control agent for drastically reducing various populations of economically important pest species (Legaspi et al., 2000). Several authors have reported that B. bassiana is effective in controlling T. urticae populations (Islam et al., 2017; Yes¸ilayer, 2018). Nevertheless, this effectiveness is influenced by factors including the quantity of conidia, relative humidity and temperature (Shipp et al., 2003; Maniania et al., 2008; Shi et al., 2008; Ullah and Lim, 2015), the crop (Seyed-Talebi et al., 2014), the spider mite population (Z´ el´ e et al., 2020) and life stage (Bugeme et al., 2015), and the fungal isolate. Thus, the varied results of pathological studies using B. bassiana to manage T. urticae are not surprising. Studies employing the commercial preparation of B. bassiana Naturalis-L obtained mortality rates from 75% (Alves et al., 2002; Shi and Feng, 2009) to 97% (Chandler et al., 2005). On the other hand, Gatarayiha et al. (2010) obtained a mortality rate of 60% in adults, yet when Naturalis-L was mixed with silicone-based surfactants the percentages increased to 85%. The Naturalis-L LC 50 for T. urticae larvae, nymphs and adults was found to be in the range of 1,949.4 to 3,184.4 conidia per mL (S´ aenz-de-Cabez´ on Irigaray et al., 2003). However, using the same product, Shipp et al. (2003) and Castagnoli et al. (2005) found no significant effect on adult T. urticae. Etoxazole is an acaricide classified as a growth inhibitor (group 10B) by the Insecticide Resistance Action Committee (IRAC, 2021) which inhibits the synthesis of chitin (Van Leeuwen et al., 2012). It is considered effective principally against tetranychid mites, but it is also useful to control aphids, grasshoppers, and moths. As an acaricide, it acts predominantly on eggs and larvae (Tirello et al., 2012), slightly less on nymphs and much less on adults (Dekeyser, 2005). To date, no studies have evaluated the compatibility of etoxazole with B. bassiana. In contrast, spirodiclofen and spiromesifen pertain to the group of chemicals derived from tetronic acids and are included in group 23 (AcetylCoA carboxylase inhibitors) which inhibit the formation of lipids and act as growth regulators (IRAC, 2021). Even though they were discovered only recently, their use has increased worldwide (Sparks and Nauen, 2015). to the fact that their mode of actions is different from the rest of the acaricides means that lipid synthesis inhibitors can be suitable to control species of pests which are resistant to other chemicals, thus facilitating Integrated Resistance Management (IRM). Spirodiclofen is highly effective against eggs and immature stages, also influences fertility and fecundity and can even kill adult death in crop pest mites (Wachendorff et al., 2002; Marcic and Ogurlic, 2006; Cheon et al., 2007). In terms of the compatibility of spirodiclofen with B. bassiana, Seyed-Talebi et al. (2014) found an interesting synergetic interaction for the control of T. urticae. On the other hand, spiromesifen is very active against juvenile stages and eggs and, although it has a strong effect on the fecundity of adults in mites and whiteflies, for example, the lethal concentrations required are very high (Nauen et al., 2005; Sato et al., 2011; Esteves Filho et al., 2013; Nicastro et al., 2013; Saryazdi et al., 2013). Very few studies have been carried out on the compatibility of B. bassiana with spiromesifen. Therefore, Seyed-Talebi et al. (2014) combined the LC 25 of spiromesifen and the LC 50 of an Iranian strain of B. bassiana and obtained an interesting synergistic effect against female adult T. urticae. However, Cuthbertson et al. (2012) observed a reduction in spore germination by this miticide for which they advise against the use of B. bassiana in mixtures. Dutta et al. (2016) studied in vitro incompatible B. bassiana with spiromesifen and Olivos Quiroz (2012), B. bassiana with spirodiclofen. Given that previous studies suggest the need to assess combinations of B. bassiana with acaricides, this study was carried out to evaluate the potential synergistic or antagonistic interactions of etoxazole, spirodiclofen and spiromesifen when mixed with B. bassiana against the eggs and larvae of T. urticae. The results of this research will enable the optimization of these combinations with a view to their effective implementation in IPM programmes. 2. Materials and methods 2.1. Colony source The T. urticae individuals used in the bioassays came from a laboratory colony maintained in the Crop Protection Laboratory of the University of La Rioja. The colony was started with individuals collected from a natural population found in the ornamental plant Impatiens walleriana Hook. f. in the city of Logro˜ no (Spain) in 2000. The T. urticae were mass-reared on green bean (Phaseolus vulgaris L., var. Garrafal) plants free of pesticides in a growth chamber at 24 ±1 ◦C, 70 ±10% RH, with a photoperiod of 16:8 (L:D). The bioassays were run in a separate growth chamber under the same environmental conditions as the mass rearing. 2.2. Synchronization of cohorts Cohorts of eggs<24 h old and neonate larvae were used in the bioassays to minimize variability due to age of individuals. To obtain the egg cohorts, T. urticae adult females were placed on green bean leaf disks (20 mm in diameter), and allowed to lay eggs for<24 h. The adult females were then removed along with the extra eggs and the same leaf discs with appreciable numbers of eggs were used in the bioassay. To obtain the larval cohorts, the adult females were placed on the underside of leaves previously isolated on damp filter paper in Petri dishes (90 mm in diameter), and allowed to lay eggs for<24 h. Isolating the leaf on damp filter paper maintained the turgor pressure of the leaf and kept the eggs isolated until larval emergence five days later. When used in bioassays, the larvae were moved to 20 mm diameter green bean leaf disks. 2.3. Commercially available pesticide products To evaluate the compatibility (synergistic, antagonistic or additive interactions) of each acaricide with B. bassiana, the LC 30 for T. urticae was employed for every compound. The LC 30 for T. urticae was calculated using the regression line of the Probit Analysis of each compound employed. The commercial acaricides used are listed in Table 1. In the case of B. bassiana, the viability of the spores was determined using the protocol by Butt and Goettel (2000). For this protocol, 30 Petri dishes (9 cm diameter) with potato-dextrose agar (PDA) culture medium was inoculated with 300 µL of a 10 -5 dilution of Naturalis-L in sterile water (S´ aenz-de-Cabez´ on Irigaray et al., 2003). The Petri dishes were incubated for 5 days at 25 ±1 ◦C, after which the mean number of colony forming units (CFUs) was calculated along with the product concentration to be used in the bioassays (CFU/mL). B. L´ opez-Manzanares et al. Biological Control 169 (2022) 104892 3 2.4. Effects of B. bassiana, etoxazole, spirodiclofen and spiromesifen on eggs and larvae The acaricide activity on T. urticae eggs and larvae was determined for each compound by obtaining the Probit Analysis regression line. Green bean leaf disks containing one cohort of the pertinent life stage were placed in 9 cm diameter Petri dishes. Each plate contained three layers of filter paper on top of a layer of moist cotton to maintain leaf disk turgor pressure and keep the bioassay individuals isolated. Each leaf disk contained ten T. urticae individuals, eggs or larvae. The concentrations previously derived from the Probit Analysis of each phytosanitary product and the life stages are listed in Table 2. For each treatment, five replicates (acaricide and B. bassiana) and controls (distilled water) were made. Treatments were carried out in a Potter tower (Burkard Rickmansworth, Herts, United Kingdom) with 5 mL of treatment solution at a pressure of 50 kPa (Potter, 1952), which was equivalent to a deposit of 0.005 ±0.0004 mL/cm 2 . Considering the length of development for each life stage, data was collected over a six-day period for eggs, and five days for larvae. However, the cohorts continued to be monitored until it was observed that the individuals were unable to hatch or to moult to the next stage, respectively; the number of live and dead individuals was recorded every day for the duration of each bioassay. 2.5. Potential synergism between B. Bassiana and etoxazole, spirodiclofen and spiromesifen For each of the three chemical acaricides evaluated, the following treatments on T. urticae eggs and larvae were carried out: 1) B. bassiana; 2) Acaricide; 3) B. bassiana +acaricide; 4) Control (distilled water). The LC 30 used were obtained in the corresponding bioassays and are listed in Table 3. The treatments were carried out in the Potter tower in the same manner as described above. In all treatments, five replications were made with 10 individuals per replicate. The mortality of eggs and larvae was recorded after seven days. 2.6. Effect of etoxazole on B. Bassiana germination and mycelial growth Due to the antagonistic interaction found in the mixture of B. bassiana with etoxazole, the effect of this chemical on conidia germination and mycelial growth was evaluated, as important factors that affect pathogenicity. For this evaluation, the PDA was sterilized in an autoclave with a pressure of 1.02 bar at 120 ◦C for 45 min, allowed to cool to 45 ◦C before mixing with etoxazole with a concentration of LC 30, the concentration previously obtained for eggs (0.029 mg/L) and larvae (0.072 mg/L). In the evaluation of the impact of etoxazole on B. bassiana conidia germination, twenty treatment Petri dishes were prepared with PDA + acaricide for each concentration while the control contained only PDA. Each Petri dish was inoculated with 300 µL of Naturalis-L diluted to 10 -5 using sterile distilled water. The Petri dishes were incubated at 25 ±1 ◦C for five days, then the number of CFUs was recorded. To analyse the effect of etoxazole on mycelial growth, a sample of B. bassiana inoculum was obtained from cultures, which had been prepared using a 10 -3 dilution of Naturalis-L on Petri dishes containing only PDA and allowed to grow for seven days at 25 ±1 ◦C. Using the point of a sterilized toothpick, a sample of the inoculum was transferred to the centre of the Petri dishes containing PDA +etoxazole or PDA only (control) and allowed to grow for five, seven and twelve days at 25 ± 1 ◦C before measuring the diameter of the fungal mycelium. Fifteen replications of each treatment and control were included in the statistical analysis. 2.7. Statistical methods Probit Analysis was using Polo Plus version 2.0 (LeOra Software, 1987) was used to estimate the LC 30 of each of the products for T. urticae eggs and larvae. For all products, the parallelism was tested between each log-Probit regression line for eggs and larvae. When the log-Probit lines were parallel, the overlap was checked between confidence intervals to determine whether the regression lines were significantly different or not at a confidence level of 95%. The χ 2 test was used to determine whether the effect produced was synergistic, additive or antagonistic when the acaricides were mixed with B. bassiana (Koppenh¨ ofer and Fuzy 2008; Morales-Rodriguez and Peck 2009). The expected mortality with a mixture (M E ) was calculated using the following formula: ME=MH+MQ(1−MH 100) Where M H is the Abbott corrected percentage mortality (Abbott, 1925) for the fungus and M Q is the Abbott corrected percentage mortality for the acaricide. The Abbott correct mortalities were calculated using the following formula: Abbot Mortality =Mtreatment −Mcontrol 100 −Mcontrol ×100 The χ 2 values were obtained using the following formula, then Table 1 Acaricides used in the laboratory trials. Active ingredient Trade name Company Concentration Formulation* Etoxazole Borneo® Kenogard S.A. 11.0% SC Spirodiclofen Envidor® Bayer CropScience S.L. 22.3% SC Spiromesifen Oberon® Bayer CropScience S.L. 22.9% SC Beauveria bassiana Naturalis-L® Agrichem S.A. 2.3 ×10 9 conidia/mL OD *SC: concentrated suspension; OD: oil dispersions. Table 2 Concentrations used to obtain the Probit-log concentration regression lines fitted for Tetranychus urticae eggs and larvae. Active ingredient Concentrations Eggs Larvae Etoxazole (mg/L) 0.007 – 0.014 – 0.028 – 0.055 – 0.110 – 0.220 0.029 – 0.065 – 0.098 – 0.147 – 0.220 Spirodiclofen (mg/L) 0.25 – 0.50 – 1.00 – 2.00 – 4.00 – 8.00 0.50 – 2.00 – 4.00 – 8.00 – 16.00 Spiromesifen (mg/L) 0.012 – 0.021 – 0.039 – 0.125 – 0.480 0.06 – 0.09 – 0.014 – 0.190 – 0.320 – 0.480 Beauveria bassiana (CFU/mL) 15,000 – 43,200 – 64,000 – 96,000 – 144,000 12,800 – 19,200 – 28,800 – 43,200 – 64,000 – 96,000 Table 3 LC 30 for the eggs and larvae of Tetranychus urticae. Active ingredient LC 30 Eggs Larvae Etoxazole 0.029 mg/L 0.072 mg/L Spirodiclofen 0.357 mg/L 1.655 mg/L Spiromesifen 0.168 mg/L 0.126 mg/L Beauveria bassiana 51,935 CFU/mL 30,691 CFU/mL B. L´ opez-Manzanares et al. Biological Control 169 (2022) 104892 4 compared to the expected values from the χ 2 Table for one degree of freedom and α =0.05. χ 2 calculated =(MQH −ME)2 ME In this formula, M QH represents the Abbott corrected percentage mortality resulting from the mixture of the acaricide and the fungus. The null hypothesis (H o ) was formulated as “there is an additive interaction between the two agents if the χ 2calculated < χ 2Table value ”. On the contrary, if χ 2calculated > χ 2Table value , the interaction was considered to be synergistic when M HQ - M E is positive; if M HQ - M E is negative, the interaction is considered antagonistic. When it was necessary, means were compared using a Student’s t test for two independent samples or a F-test of analysis of variance (ANOVA) followed by the Tukey multiple comparisons test ( α =0.05). 3. Results 3.1. Effects of B. bassiana, etoxazole, spirodiclofen and spiromesifen on T. Urticae eggs and larvae Table 4 lists the Probit Analysis results for the effects of B. bassiana and the three acaricides on T. urticae eggs and larvae. The data were recorded and the regression lines were calculated five days after treatment for eggs and six for larvae. The equality and parallelism tests between the Probit-log lines obtained for B. bassiana in eggs and larvae resulted in the rejection of the null hypothesis. The LC 50 and LC 99 of this entomopathogenic fungus, with the slope of the Probit-log regression line steeper for the larval stage than the egg stage, indicate greater effectiveness on larvae than on eggs. In the case of etoxazole and spirodiclofen, the null hypothesis was rejected for equality and accepted for parallelism. The egg stage was the most sensitive for both acaricides. The relative potency values were 2.5 for etoxazole and 4.6 for spirodiclofen; that is, the effect on eggs is 2.5 and 4.6 times greater than in larvae respectively for both compounds. Finally, the regression lines obtained for the effect of spiromesifen on eggs and larvae were neither equal nor parallel. However, the LC 50 and LC 99 did not present significant differences between the effect on eggs and larvae, due to the overlap of the confidence intervals in both lethal concentrations. 3.2. Potential synergy between B. Bassiana and etoxazole, spirodiclofen and spiromesifen The combination of B. bassiana and etoxazole resulted in an interaction considered antagonistic on T. urticae eggs (Table 5) and larvae (Table 6). The mixtures of B. bassiana with spirodiclofen and B. bassiana with spiromesifen instead both resulted in additive interactions, on both mite eggs and larvae (Tables 5 and 6, respectively). 3.3. Effects of etoxazole on B. Bassiana germination and mycelial growth. There were no significant differences between the number of CFUs in the control dishes (30.47 ±11.32) and in the dishes treated with etoxazole LC 30 for T. urticae eggs (32.33 ±9.59) (t =-0.49; P =0.6299) nor for the LC 30 for larvae (34.40 ±7.10) (t =-1.14; P =0.2641). Thus, etoxazole is compatible with the conidia germination of B. bassiana. In addition, the LC 30 for eggs caused no significant reduction in mycelial growth in this fungus at five days (t =0.98; P =0.3387) or at seven days (t =0.66; P =0.5140). However, at 12 days, the mycelial diameter was 3.16% lower in the etoxazole replications (t =5.20; P <0.0001) than in the control (Table 7). Similarly, the LC 30 for etoxazole on larvae caused no significant reduction in mycelial growth in this fungus at 5 days (t = 0.27; P =0.7924, or at 7 days (t =0.50; P =0.1474). However, at 12 days, the mycelial diameter was 7.19% lower in the etoxazole treatment (t =2.83; P =0.0096) than in the control (Table 7). 4. Discussion This study investigates the effectiveness and compatibility of several acaricides with B. bassiana, with a view to incorporating the use of such mixtures into the Integrated Pest Management of the two-spotted spider mite. Considering B. bassiana alone, the T. urticae eggs were less susceptible than larvae (LC 50 =1.12 ×10 5 CFU/mL and 48,261 CFU/mL, respectively). This lower susceptibility of the eggs agrees with the observations of S´ aenz-de-Cabez´ on Irigaray et al. (2003) and could be explained by the topography of the chorion, which can make it difficult for conidia to establish (Leger et al. 1991). Due to the important influence that the composition of substrate has on this fungus, the nutrients found on the egg surface could play a key role in the germination and development of B. bassiana (Bidochka and Khachatourians 1992; Napolitano and Ju´ arez 1997). Etoxazole, on the other hand, is an acaricide that acts mainly on eggs and larvae (Tirello et al. 2012), which explains why the LC 50 obtained in this study are considerably inferior to those found for adults by other authors such as Nicastro et al. (2013). The results show lower susceptibility of T. urticae larvae than eggs. The results for the LC 50 calculated for eggs are within the same range found by Tirello et al. (2012) in various Italian populations. There are no previous studies that evaluate the compatibility of etoxazole and B. bassiana. The mixture resulted in an antagonistic interaction in eggs and larvae. This antagonistic effect could not be attributed to either the conidial germination or the mycelial growth of the fungus, given that there was no effect seen aside from a slight reduction in mycelial diameter in the longer term. Spirodiclofen is another chemical that is considered exceptionally effective against eggs and immature stages of phytophagous mites. It has less effect on adult females even though it does seriously affect fecundity and fertility, provoking death in a very few days (Wachendorff et al. Table 4 Parameters of the Probit-log concentration regression lines fitted for Tetranychus urticae eggs and larvae, treated with Beauveria bassiana, etoxazole, spirodiclofen and spiromesifen. Active ingredients Development stage Probit equation χ 2 calculated (df) * LC 10 (fl, 95%)** LC 50 (fl, 95%)** LC 99 (fl, 95%)** B. bassiana Eggs y =-2.94 +1.57 x 0.397 (3) 17,130 (5,065–28,311) 1.12 ×10 5 (84,115–1.85 × 10 5 ) 3.38 ×10 6 (1.01 ×10 6 – 7.66 × 10 7 ) Larvae y =-7.49 +2.67 x 1.832 (3) 15,965 (11,672–19,862) 48,261 (41,267–57,668) 3.59 ×10 5 (2.34 ×10 5 – 6.96 × 10 5 ) Etoxazole Eggs y =10.46 +3.88 x 1.979 (4) 0.018(0.013–0.023) 0.039 (0.033–0.046) 0.156 (0.116–0.255) Larvae y =8.72 +3.72 x 0.924 (3) 0.045 (0.034–0.054) 0.100 (0.088–0.112) 0.421 (0.320–0.641) Spirodiclofen Eggs y =5.55 +2.40 x 1.070 (4) 0.173 (0.099–0.247) 0.590 (0.460–0.724) 5.484 (3.642–10.424) Larvae y =3.94 +2.46 x 6.392 (3) 0.815 (0.158–1.499) 2.704 (1.454–4.268) 23.829 (11.182–208.036) Spiromesifen Eggs y =7.21 +3.53 x 4.069 (3) 0.103 (0.029–0.158) 0.237 (0.152–0.388) 1.080 (0.560–11.251) Larvae y =9.07 +5.12 x 7.041 (4) 0.090 (0.062–0.111) 0.160 (0.134–0.192) 0.455 (0.332–0.853) *df degree of freedom; **fl fiducial limits. B. L´ opez-Manzanares et al. Biological Control 169 (2022) 104892 5 2002; Marcic and Ogurlic 2006; Cheon et al. 2007; Seyed-Talebi et al. 2014). Marcic and Ogurlic (2006) found larvae to be more sensitive than eggs, which is in contrast to the findings in our bioassays that showed that the LC 50 for larvae was much higher than for eggs (2.70 g/mL and 0.59 g/mL, respectively). Regarding the lethal concentrations of spirodiclofen for T. urticae eggs, previous studies show similar values to those obtained in our study (Rauch and Nauen, 2003; Tirello et al. 2012; Saryazdi et al., 2013). In relation to the compatibility of B. bassiana with spirodiclofen, Seyed-Talebi et al. (2014) found the mixture produced a synergistic interaction in adults. In the current research, however, the effect was additive for both eggs and larvae. From the point of view of the incorporation of spirodiclofen in IPM programmes, the demography of the population must be kept in mind. The majority—-90% of the individuals in stable natural populations of this mite—consists of eggs and immature stages (Carey 1982; Helle and Sabelis 1985) which are precisely those most sensitive to spirodiclofen. In addition to its different mode of action based on the inhibition of lipid synthesis, this acaricide has the advantage of effectiveness in resistant populations of mites (Nauen et al. 2000; Elbert et al. 2002; Dekeyser 2005). The only negative aspect of spirodiclofen is its poor efficacy in adults; however, keeping in mind the synergistic interaction found by Seyed-Talebi et al. (2014) with B. bassiana, this acaricide could be an interesting option for mixtures to treat T. urticae populations. In various European countries, spirodiclofen at 96 mg/L is an adequate concentration to control populations of T. urticae (Elbert et al. 2002). Field trials and laboratory bioassays employing concentrations between 48 and 96 mg/L, and or applications of 240 g/ha (Wolf and Schnorbach 2002; de Maeyer et al. 2002; Hardman et al. 2003; Reis et al. 2006; Cheon et al. 2007) have had an effect on survival and fecundity in various species of predatory mites. These findings support the ideal strategies, which use lower concentrations permitting the integration of biological control agents. In respect to spiromesifen, T. urticae larvae and eggs showed similar susceptibilities. This acaricide acts best on eggs and larvae, so the lethal concentrations for adults are higher (Nauen et al. 2005; Sato et al. 2011; Esteves Filho et al. 2013; Nicastro et al. 2013; Saryazdi et al., 2013). There have been very few studies on the compatibility of spiromesifen with B. bassiana. Cuthbertson et al. (2012) detected a reduction in fungal spore germination; thus, they advise against mixing the two. However, upon mixing these products in our study, we found an additive interaction in both larvae and eggs. There does not appear to be any advantage to using this combination, though neither is there any reduction in effectiveness. In summary, the results of this research show that the antagonistic effect between B. bassiana and etoxazole precludes their combined use in the management of eggs and larvae of T. urticae. In contrast, B. bassiana Table 5 Effect of combinations of Beauveria bassiana and etoxazole, spirodiclofen and spiromesifen on Tetranychus urticae egg mortality. Treatment Mortality (Mean ±SE)* χ 2calculated ( α =0.05, df =1) χ 2Table value ( α =0.05, df =1) D** Statistics Control 7.14 ±1.84 a B. bassiana 34.29 ±6.85b Etoxazole 32.86 ±3.60b B. bassiana +Etoxazole 34.29 ±6.12b 7.866 3.841 −19.60 F 3,24 =7.08; P <0.0014 Control 7.14 ±1.84 a B. bassiana 34.29 ±6.85 bc Spirodiclofen 24.29 ±6.12 ab B. bassiana +Spirodiclofen 51.43 ±7.38c 0.689 3.841 – F 3,24 =9.67; P <0.0000 Control 7.14 ±1.84 a B. bassiana 34.29 ±6.85 bc Spiromesifen 20.00 ±7.87 ab B. bassiana +Spiromesifen 41.43 ±6.70c 0.114 3.841 – F 3,24 =5.92; P <0.0036 *Means within a B. bassiana – acaricide combination followed by the same letter are not significantly different at the 5% level (ANOVA and LSD). **D =(MHQ - ME) < 0 a significant antagonistic interaction. Table 6 Effect of combinations of Beauveria bassiana and etoxazole, spirodiclofen and spiromesifen on Tetranychus urticae larva mortality. Treatment Mortality (Mean ±SE)* χ 2calculated ( α =0.05, df =1) χ 2Table value ( α =0.05, df =1) D** Statistics Control 0.00 ±0.00 a B. bassiana 27.14 ±5.22b Etoxazole 38.57 ±8.00b B. bassiana +Etoxazole 31.43 ±7.69b 10.267 3.841 –23.82 F 3.24 =7.57; P <0.0010 Control 0.00 ±0.00 a B. bassiana 27.14 ±5.22c Spirodiclofen 12.86 ±2.86b B. bassiana +Spirodiclofen 42.86 ±5.65 d 1.103 3.841 – F 3.24 =20.24; P <0.0000 Control 0.00 ±0.00 a B. bassiana 27.14 ±5.22b Spiromesifen 12.86 ±3.60 ab B. bassiana +Spiromesifen 45.71 ±8.12c 2.320 3.841 – F 3.24 =14.51; P <0.0000 *Means within a B. bassiana – acaricide combination followed by the same letter are not significantly different at the 5% level (ANOVA and LSD). **D =(M HQ - M E ) < 0 a significant antagonistic interaction. Table 7 Radial mycelial in vitro growth of Beauveria bassiana (Mean ±SE) at 5, 7 and 12 days after inoculation with addition of etoxazole at a concentration to the LC 30 for eggs and larvae of Tetranychus urticae. Treatment Mycelial growth (cm) % inhibition 5 days 7 days 12 days 5 days 7 days 12 days Control (B. bassiana alone) 1.51 ± 0.05 2.48 ± 0.06 4.75 ± 0.10 B. bassiana + Etoxazole (0.029 mg/L) 1.49 ± 0.03 2.47 ± 0.07 4.60 ± 0.00* – – 3.16 B. bassiana + Etoxazole (0.072 mg/L) 1.50 ± 0.10 2.43 ± 0.12 4.41 ± 0.41* – – 7.19 *Means significantly different in regard to the control (t-Student; α =0.05). B. L´ opez-Manzanares et al. Biological Control 169 (2022) 104892 6 can be combined with both spirodiclofen and spiromesifen for improved treatment against T. urticae. However, results show that the effectiveness in treating these stages of the mite requires product concentrations to be maintained without reduction. 5. Author statement The authors of the manuscript are: Beatriz L´ opez-Manzanares (BLM); Elena Martínez-Villar (EMV); Vicente S. Marco-Manceb´ on (VSMM) and Ignacio P´ erez-Moreno (IPM). •BLM, VSMM and IPM conceived and designed research. •BLM and EMV conducted experiments and acquired the data. •BLM, VSMM and IPM analyzed data. •BLM, VSMM and IPM wrote the manuscript. •BLM, EMV, VSMM and IPM revising the manuscript critically for important intellectual content. Finally, all the authors read and approved the manuscript. •BLM, EMV, VSMM and IPM participated in the article submission and review process. Acknowledgements The authors would like to thank the professional language editing service for improving the quality of the English. References Alves, S.B., Rossi, L.S., Lopes, R.B., Tamai, M.A., Pereira, R.M., 2002. Beauveria bassiana yeast phase on agar medium and its pathogenicity against Diatraea saccharalis (Lepidoptera: Crambidae) and Tetranychus urticae (Acari: Tetranychidae). J. Invertebr. Pathol. 81 (2), 70–77. https://doi.org/10.1016/S0022-2011(02)001477. Bidochka, M.J., Khachatourians, G.G., 1992. Growth of the entomopathogenic fungus Beauveria bassiana on cuticular components from the migratory Grasshopper, Melanopus sanguinipes. J. Invertebr. Pathol. 59, 165–173. https://doi.org/10.1016/ 0022-2011(92)90028-3. Bugeme, D.M., Knapp, M., Ekesi, S., Chabi-Olaye, A., Boga, H.I., Maniania, N.K., 2015. Efficacy of Metarhizium anisopliae in controlling the two-spotted spider mite Tetranychus urticae on common bean in screenhouse and field experiments. Insect Sci. 22 (1), 121–128. https://doi.org/10.1111/1744-7917.12111. Butt, T.M., Goettel, M.S., 2000. Bioassays of entomogenous fungi. In: Navon, A., Ascher, K.R.S. (Eds.), Bioassays of entomopathogenic microbes and nematodes. CAB International, Wallingford, UK, pp. 141–196. Carey, J.R., 1982. Demography of the two-spotted spider mite Tetranychus urticae Koch. Oecologia 52 (3), 389–395. https://doi.org/10.1007/BF00367964. Castagnoli, M., Liguori, M., Simoni, S., Duso, C., 2005. Toxicity of some insecticides to Tetranychus urticae, Neoseiulus californicus and Tydeus californicus. Biocontrol 50 (4), 611–622. https://doi.org/10.1007/s10526-004-8121-7. Chandler, D., Davidson, G., Jacobson, R.J., 2005. Laboratory and glasshouse evaluation of entomopathogenic fungi against the two-spotted spider mite, Tetranychus urticae (Acari: Tetranychidae), on tomato, Lycopersicon esculentum. Biocontrol Sci. Tech. 15 (1), 37–54. https://doi.org/10.1080/09583150410001720617. Cheon, G.S., Paik, C.H., Lee, G.H., Kim, S.S., 2007. Toxicity of spirodiclofen to the predatory mite, Amblyseius womersleyi (Acari: Phytoseiidae), and its prey, Tetranychus urticae (Acari: Tetranychidae). J. Entomol. Sci. 42, 44–51. https://doi. org/10.18474/0749-8004-42.1.44. Cuthbertson, A.G.S., Buxton, J.H., Blackburn, L.F., Mathers, J.J., Robinson, K.A., Powell, M.E., Fleming, D.A., Bell, H.A., 2012. Eradicating Bemisia tabaci Q biotype on poinsettia plants in the UK. Crop Prot. 42, 42–48. https://doi.org/10.1016/j. cropro.2012.08.009. De Maeyer, L., Schmidt, H.W., Peeters, D., 2002. Envidor - a new acaricide for IPM in pomefruit orchards. Pflanzenschutz-Nachrichten Bayer 55, 211–236. Dekeyser, M.A., 2005. Acaricide mode of action. Pest Manag. Sci. 61 (2), 103–110. https://doi.org/10.1002/ps.994. Dutta, P., Bhattacharyya, P.N., Sarmah, S.R., Madhab, M., Sandilya, S.P., Gogoi, D., Ivy, P., Begum, R., Tanti, A.J., Pathak, S.K., 2016. In vitro studies on the compatibility assessment of certain agrochemicals with microbial biopesticides used in tea [Camellia sinensis (L.) O. Kuntze] of Assam . Northeast India Two and a Bud 63 (1), 13–16. Elbert, A., Brück, E., Sone, S., Toledo, A., 2002. Worldwide use of the new acaricide Envidor® in perennial crops. Pflanzenschutz-Nachrichten Bayer 55, 287–304. Esteves Filho, A.B., Vargas de Oliveira, J., Braz Torres, J., Cysneiros Matos, C.H., 2013. Toxicity of spiromesifen and natural acaricides to Tetranychus urticae Koch and compatibility with Phytoseiulus macropilis (Banks). Ciˆ encias Agr´ arias, Londrina 34, 2675–2686. https://doi.org/10.5433/1679-0359.2013v34n6p2675. Gatarayiha, M.C., Laing, M.D., Miller, R.M., 2010. Effects of adjuvant and conidial concentration on the efficacy of Beauveria bassiana for the control of the two-spotted spider mite, Tetranychus urticae. Exp. Appl. Acarol. 50 (3), 217–229. https://doi.org/ 10.1007/s10493-009-9307-6. Hardman, J.M., Franklin, J.L., Moreau, D.L., Bostanian, N.J., 2003. An index for selective toxicity of miticides to phytophagous mites and their predators based on orchard trials. Pest Manag. Sci. 59 (12), 1321–1332. https://doi.org/10.1002/ps.769. Helle, W., Sabelis, M.W., 1985. Spider Mites: Their Biology. Natural Enemies and Control, Elsevier, Amsterdam. Islam, T., Biswas, M.J.H., Howlader, M.T.H., Ullah, M.S., 2017. Laboratory evaluation of Beauveria bassiana, some plant oils and insect growth regulators against two-spotted spider mite, Tetranychus urticae Koch (Acari: Tetranychidae). Persian J. Acarol. 6, 203–211. https://doi.org/10.22073/pja.v6i3.29338. IRAC, 2021. Insecticide Resistance Action Committee Web. http://www.irac-online.org/ modes-of-action/. Accessed 12 November 2021. Koppenh¨ ofer, A.M., Fuzy, E.M., 2008. Early timing and new combinations to increase the efficacy of neocicotinoid-entomopathogenic nematode (Rhabditida: Heterorhabditidae) combinations against white grubs (Coleoptera: Scarabaeidae). Pest Manag. Sci. 64, 725–735. https://doi.org/10.1002/ps.1550. Legaspi, J.C., Poprawski, T.J., Legaspi, B.C., 2000. Laboratory and field evaluation of Beauveria bassiana against sugarcane stalkborers (Lepidoptera: Pyralidae) in the Lower Rio Grande Valley of Texas. J. Econ. Entomol. 93, 54–59. https://doi.org/ 10.1603/0022-0493-93.1.54. LeOra Software, 1987. POLO-PC, user’s guide to probit or logit analysis. LeOra Software Inc, Berkeley, CA. Maniania, N., Bugeme, D., Wekesa, V., Delailibera, I., Knapp, M., 2008. Role of entomopathogenic fungi in the control of Tetranychus evansi and Tetranychus urticae (Acari: Tetranychidae), pests of horticultural crops. Exp. Appl. Acarol. 46, 259–274. https://doi.org/10.1007/978-1-4020-9695-2_21. Marcic, D., Ogurlic, I., 2006. Lethal and sublethal efects of spirodiclofen on two-spotted spider mite (Acari: Tetranychidae). Pestic. Phytomed. 21, 137–143. Morales-Rodriguez, A., Peck, D.C., 2009. Synergies between biological and neonicotinoid insecticides for the curative control of the white grubs Amphimallon majale and Popillia japonica. Biol. Control 51 (1), 169–180. https://doi.org/10.1016/j. biocontrol.2009.06.008. Napolitano, R., Ju´ arez, M.P., 1997. Entomopathogenous fungi degrade epicuticular hidrocarbons of Triatoma infestans. Arch. Biochem. Biophys. 344, 208–214. https:// doi.org/10.1006/abbi.1997.0163. Nauen, R., Schnorbach, H.J., Elbert, A., 2005. The biological profile of spiromesifen (Oberon®) - A new tetronic acid insecticide/acaricide. PflanzenschutzNachrichten Bayer, Leverkusen 58, 417–440. Nauen R, Stumpf N, Elbert A (2000) Efficacy of BAJ 2740, a new acaricidal tetronic acid derivative, against tetranychid spider mite species resistant to conventional acaricides. In: Proc Brighton Crop Protection Conf - Pests & Diseases 2000, pp 1: 453–458. Nicastro, R.L., Sato, M.E., Arthur, V., da Silva, M.Z., 2013. Chlorfenapyr resistance in the spider mite Tetranychus urticae: Stability, cross-resistance and monitoring of resistance. Phytoparasitica 41 (5), 503–513. https://doi.org/10.1007/s12600-0130309-x. Olivos Quiroz R.D.V., 2012. Compatibilidad entre Beauveria bassiana y el insecticida spirodiclofen en condiciones de laboratorio (tesis de pregrado título Bi´ ologoMicrobi´ ologo). Universidad de Trujillo, Perú. Potter, 1952. An improved laboratory apparatus for appliying direct sprays and surface films, with data on the electrostatic charge on atomized spray fluids. Ann Appl Biol 39:1-28. https://doi.org/10.1111/j.1744-7348.1952.tb00993.x. Rauch, N., Nauen, R., 2002. Spirodiclofen resistance risk assessment in Tetranychus urticae (Acari: Tetranychidae): a biochemical approach. Pestic. Biochem. Physiol. 74 (2), 91–101. https://doi.org/10.1016/S0048-3575(02)00150-5. Reis, P.R., Franco, R.A., Neto, M.P., Teodoro, A.V., 2006. Selectivity of agrochemicals on predatory mites (Phytoseiidae) found on coffee plants. Coffee Sci 1, 64–70. S´ aenz-de-Cabez´ on Irigaray, F.J., Marco-Manceb´ on, V., P´ erez-Moreno, I., 2003. The entomopathogenic fungus Beauveria bassiana and its compatibility with triflumuron: effects on the two-spotted spider mite, Tetranychus urticae. Biol. Control 26 (2), 168–173. https://doi.org/10.1016/S1049-9644(02)00123-8. Askari Saryazdi, G., Hejazi, M.J., Amizadeh, M., 2013. Lethal and sublethal effects of spiromesifen, spirotetramat and spirodiclofen on Tetranychus urticae Koch (Acari: Tetranychidae). Arch. Phytopathol. Plant Protect. 46 (11), 1278–1284. https://doi. org/10.1080/03235408.2013.764074. Sato, M.E., da Silva, M.Z., Raga, A., Cangani, K.G., Veronez, B., Nicastro, R.L., 2011. Spiromesifen toxicity to the spider mite Tetranychus urticae and selectivity to the predator Neoseiulus californicus. Phytoparasitica 39 (5), 437–445. https://doi.org/ 10.1007/s12600-011-0189-x. Seyed-Talebi, F.-S., Kheradmand, K., Talaei-Hassanloui, R., Talebi-Jahromi, K., 2014. Synergistic effect of Beauveria bassiana and spirodiclofen on the two-spotted spider mite (Tetranychus urticae). Phytoparasitica 42 (3), 405–412. https://doi.org/ 10.1007/s12600-013-0377-y. Shi, W.-B., Feng, M.-G., 2009. Effect of fungal infection on reproductive potential and survival time of Tetranychus urticae (Acari: Tetranychidae). Exp. Appl. Acarol. 48 (3), 229–237. https://doi.org/10.1007/s10493-009-9238-2. Shi, W.-B., Feng, M.-G., Liu, S.-S., 2008. Sprays of emulsifiable Beauveria bassiana formulation are ovicidal towards Tetranychus urticae (Acari: Tetranychidae) at various regimes of temperature and humidity. Exp. Appl. Acarol. 46 (1-4), 247–257. https://doi.org/10.1007/s10493-008-9172-8. Shipp, J.L., Zhang, Y., Hunt, D.W.A., Ferguson, G., 2003. Influence of humidity and greenhouse microclimate on the efficacy of Beauveria bassiana (Balsamo) for control B. L´ opez-Manzanares et al. Biological Control 169 (2022) 104892 7 of greenhouse. Environ. Entomol. 32, 1154–1163. https://doi.org/10.1603/0046225X-32.5.1154. Sparks, T.C., Nauen, R., 2015. IRAC: Mode of action classification and insecticide resistance management. Pestic. Biochem. Physiol. 121, 122–128. https://doi.org/ 10.1016/j.pestbp.2014.11.014. Leger, R.J.S., Goettel, M., Roberts, D.W., Staples, R.C., 1991. Prepenetration events during infection of host cuticle by Metarhizium anisopliae. J. Invertebr. Pathol. 58 (2), 168–179. https://doi.org/10.1016/0022-2011(91)90061-T. Tirello, P., Pozzebon, A., Cassanelli, S., Van Leeuwen, T., Duso, C., 2012. Resistance to acaricides in Italian strains of Tetranychus urticae: toxicological and enzymatic assays. Exp. Appl. Acarol. 57 (1), 53–64. https://doi.org/10.1007/s10493-0129536-y. Ullah, M.S., Lim, U.T., 2015. Laboratory bioassay of Beauveria bassiana against Tetranychus urticae (Acari: Tetranychidae) on leaf discs and potted bean plants. Exp. Appl. Acarol. 65 (3), 307–318. https://doi.org/10.1007/s10493-014-9871-2. Van de Vrie, M., 1985. Control of Tetranychidae in crops: Greenhouses ornamentals. In: Helle, W., Sabelis, M.W. (Eds.), Spider mites: Their Biology, Natural Enemies and Control. Elsevier, Amsterdan, pp. 273–283. Van Leeuwen, T., Demaeght, P., Osborne, E.J., Dermauw, W., Gohlke, S., Nauen, R., Grbi´ c, M., Tirry, L., Merzendorfer, H., Clark, R.M., 2012. Population bulk segregant mapping uncovers resistance mutations and the mode of action of a chitin synthesis inhibitor in arthropods. PNAS 109 (12), 4407–4412. https://doi.org/10.1073/ pnas.1200068109. Wachendorff, U., Nauen, R., Schnorbach, H.J., Rauch, N., Elbert, A., 2002. The biological profile of spirodiclofen (Envidor®) a new selective tetronic acid acaricide. Pflanzenschutz-Nachrichten Bayer 55, 149–176. Wolf, G., Schnorbach, H.J., 2002. Ecobiological profile of the acaricide spirodiclofen. Pflanzenschutz-Nachrichten Bayer 55, 177–196. Yes¸ilayer, A., 2018. Efficiency of two different entomopathogen fungi Beauveria bassiana and Purpureocillium lilacinum TR1 against Tetranychus urticae. Appl. Ecol. Environ. Res. 16, 6077–6086. https://doi.org/10.15666/aeer/1605_60776086. Z´ el´ e, F., Altıntas¸, M., Santos, I., Cakmak, I., Magalh˜ aes, S., 2020. Interand intraspecific variation of spider mite susceptibility to fungal infections: Implications for the longterm success of biological control. Ecol. Evol. 10 (7), 3209–3221. https://doi.org/ 10.1002/ece3.5958. B. L´ opez-Manzanares et al.